Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Quantum Genesis AI (QTZM) EBITDA Margin (2016 - 2018)

Quantumzyme's EBITDA Margin history spans 4 years, with the latest figure at 1.08% for Q2 2018.

  • For Q2 2018, EBITDA Margin fell 2726.0% year-over-year to 1.08%; the TTM value through Oct 2024 reached 228.55%, changed N/A, while the annual FY2018 figure was 13.81%, 1636.0% up from the prior year.
  • EBITDA Margin reached 1.08% in Q2 2018 per QTZM's latest filing, up from 0.86% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 28.34% in Q2 2017 to a low of 90.47% in Q4 2016.
  • Average EBITDA Margin over 4 years is 12.6%, with a median of 1.21% recorded in 2016.
  • Peak YoY movement for EBITDA Margin: crashed -8324bps in 2016, then surged 8242bps in 2017.
  • A 4-year view of EBITDA Margin shows it stood at 7.23% in 2015, then plummeted by -1151bps to 90.47% in 2016, then surged by 91bps to 8.05% in 2017, then surged by 113bps to 1.08% in 2018.
  • Per Business Quant, the three most recent readings for QTZM's EBITDA Margin are 1.08% (Q2 2018), 0.86% (Q1 2018), and 8.05% (Q4 2017).